phase readout
saveNCT06551116: QuantifyHER: Quantitative Immunofluorescence and/or RT-qPCR for Measuring HER2 in HER2-low Metastatic Breast Cancer
RECRUITINGupdated 6d ago
community read0 votes
Sponsor: Abramson Cancer Center at Penn Medicine. Phase: . Conditions: HER2-positive Metastatic Breast Cancer
view source ↗
comments(0)
5-min edit window · permanent after that